The US Food and Drug Administration is asking its external experts to examine several scientific issues that may affect the regulation of dental amalgam, used for direct filling of carious lesions or structural defects in teeth. The advisory panel, the agency said, will meet on 14 and 15 December. ...
Please Login to read the full article.
